A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.
Back
Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME
A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.
Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME
Episodes
All
All
A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.
Advertisement
Advertisement
Trending on HCPLive
1
Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy
2
Bimekizumab Data Support Case for Earlier Intervention in HS
3
A Genetic Signature May Predict Who Gets Sick From CAR T Cell Therapy
4
Rethinking HFpEF Screening and Care, With Ronald D'Agostino, DO
5